Inventor · disambiguated record
Philipp Rubenbauer
Also filed as: RUBENBAUER PHILIPP
9 granted patents·4 pending applications·5 citations·filing 2015–2022
78Inventor score
Top patents by PatentIndex Score
13 records- 0183US10905667B2Orally administrable modified-release pharmaceutical dosage formBayer Pharma AG·Filed 2018·Granted Feb 2, 2021·2 cites·25 claims
- 0271US2022234996A1Method for Producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic Acid and the Crystalline Form Thereof for Use as a Pharmaceutical IngredientBayer Pharma AG·Filed 2022·Application pending·0 cites
- 0369US10316001B2Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrohydro pyrimidine-5-carbonitrilePH PHARMA CO LTD·Filed 2016·Granted Jun 11, 2019·1 cites·18 claims
- 0468US10494372B2Synthesis of copanlisib and its dihydrochloride saltBayer Pharma AG·Filed 2015·Granted Dec 3, 2019·2 cites·19 claims
- 0568US2022257547A1Orally administrable modified-release pharmaceutical dosage formBayer Pharma AG·Filed 2022·Application pending·0 cites
- 0666US11344519B2Orally administrable modified-release pharmaceutical dosage formBayer Pharma AG·Filed 2020·Granted May 31, 2022·0 cites·2 claims
- 0763US11332435B2Method for producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4- chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic acid and the crystalline form thereof for use as a pharmaceutical ingredientBayer Pharma AG·Filed 2018·Granted May 17, 2022·0 cites·1 claims
- 0863US10676443B2Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydro pyrimidine-5-carbonitrilePH PHARMA CO LTD·Filed 2019·Granted Jun 9, 2020·0 cites·7 claims
- 0958US10703742B2Method for producing 5-hydroxyalkyl-substituted 1-phenyl-1,2,4-triazole derivativesBayer Pharma AG·Filed 2017·Granted Jul 7, 2020·0 cites·10 claims
- 1058US2020299271A1Method for producing 5-hydroxyalkyl-substituted 1-phenyl-1,2,4- triazole derivativesBayer Pharma AG·Filed 2020·Application pending·0 cites
- 1146US11365179B2Method for the preparation of a 2,4,5-trisubstituted 1,2,4-triazoloneBAYER AG·Filed 2019·Granted Jun 21, 2022·0 cites·20 claims
- 1240US2020237648A1Orally administrable modified-released pharmaceutical dosage formBAYER AG·Filed 2019·Application pending·0 cites
- 1334US12258343B2Method for preparing 2-[(3R)-3-methylmorpholin-4-yl]-4-[1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridineBAYER AG·Filed 2019·Granted Mar 25, 2025·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Philipp Rubenbauer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →